1. Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.
   Amila Suraweera et al, 2018, Front Oncol CrossRef
2. In vitro models of molecular and nano-particle transport across the blood-brain barrier
   Cynthia Hajal et al, 2018, Biomicrofluidics CrossRef
3. Inhibition of human constitutive 20S proteasome and 20S immunoproteasome with novel N -terminally modified peptide aldehydes and their antitumor activity
   Lubos Marta et al, 2018, Peptide Science CrossRef
4. A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
   Elisabete Cruz Da Silva et al, 2021, Cancers CrossRef
5. Role of stress granules in modulating senescence and promoting cancer progression: Special emphasis on glioma
   Debmita Chatterjee et al, 2021, Int. J. Cancer CrossRef
6. Production of Epoxyketone Peptide-Based Proteasome Inhibitors by Streptomyces sp. BRA-346: Regulation and Biosynthesis
   Bruna Domingues Vieira et al, 2022, Front. Microbiol. CrossRef
7. Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress–induced cell death
   Narathip Naradun et al, 2022, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef